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1. The role of allopurinol in the protection of kidney 
function following ischaemia-reperfusion injury has 
been investigated using the novel technique of near- 
infrared spectroscopy.
2. An in vivo model of rat kidney ischaemia was 
used, with the expected falls in blood and tissue 
oxygenation seen and confirmed by near-infrared 
spectroscopy.
3. Allopurinol infusion increased the rate of reperfu­
sion of oxygenated blood seen in control rats
(P  <  0.05).
4. Allopurinol enhanced the rate of tissue oxygena­
tion during early reperfusion (P<0.01).
5. This study provides further evidence for the pro­
posed benefits of allopurinol in ischaemia-reperfusion 
injury. Furthermore, the potential of near-infrared 
spectroscopy as a technique of value in interventional 
studies of this nature is confirmed.
INTRODUCTION
Ischaemia-reperfusion injury is a major cause of 
acute renal failure [1] and of probable importance 
in transplantation. The kidney is highly susceptible 
to ischaemic injury, particularly the renal intersti- 
tium, where tissue oxygenation is often critical [2 -  
5]. Ischaemia results in depletion of high-energy 
adenine nucleotides, mitochondrial damage and an 
inability to maintain cell membrane ion gradients. 
During reperfusion with oxygenated blood, further 
injuries occur in response to the release of reactive 
oxygen species.
This study uses the technique of near-infrared 
spectroscopy (NIRS) to investigate further blood 
and, more importantly, tissue oxygenation in an in 
vivo model of ischaemia-reperfusion. This methodo­
logy uses an optical technique dependent on the 
absorption properties of two biological chromo-
phores, haemoglobin and mitochondrial cytochrome
f
a, a3 (cyt aa3), and is able to monitor simulta­
neously blood and tissue oxygenation. Optical 
methods have previously revealed invaluable infor­
mation regarding renal tissue oxygenation both in 
vivo and in vitro [5-8]. We have already, using 
NIRS, studied the oxygenation changes and eva­
luated the injury that occurs in the in vivo model 
used here [9, 10]. We now apply that model to 
evaluate further the putative beneficial effects of 
allopurinol as it is believed to protect the kidney 
against ischaemia-reperfusion in several ways, in­
cluding inhibition of xanthine oxidase, which both 
reduces the release of reactive oxygen species during 
reperfusion and prevents the degradation of adenine 
nucleotides [11]. Allopurinol has also been shown 
to scavenge reactive oxygen species and enhance the 
electron transport chain [12, 13]. The aims of this 
study were to determine whether or not allopurinol 
alters tissue reperfusion at an early stage and to 
confirm the ability of NIRS to detect changes in 
tissue oxygenation.
METHODS 
NIRS [14]
The NIR range is the most useful spectroscopic 
range with which to monitor light absorbance in 
biological tissue as blood has high absorbance at 
wavelengths less than 700 nm and greater light- 
scattering effects beyond 1000 nm [15]. Blood in its 
deoxygenated form (Hb) demonstrates a peak absor­
bance at 775 nm. The terminal member of the 
respiratory chain, cyt aa3, shows a broad absorption 
peak [16-19] at 845 nm when fully oxidized in 
purified preparations [18, 19]. A third wavelength 
(904 nm) is also used for monitoring [20]. The 
optical absorbance changes of the chromophores, 
Hb, oxygenated haemoglobin (H b02) and cyt aa2 
provide the basis for the NIRS technique.
The relationship between optical absorbance and
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chromophore concentration can be expressed by a 
modified Beer-Lambert Law as
A = e C n L  +  B
where A = optical absorbance, C  =  concentration of 
either Hb, H b 0 2, Hbtot or cyt aa3 (mmol/1), e =  
absorption coefficient for either parameter 
(1/cmxmmol), L=physical pathlength (interprobe 
distance/cm), B =  absorbance losses and n =  path­
length multiplication factor.
Scattering of light by biological tissue makes the 
actual pathlength many times more than the physi­
cal pathlength. For example, the optical pathlength 
in the neonatal brain is approximately 4.3 times the 
interoptode distance [21]. In the rat kidney the 
interoptode distance was set at 1 cm. The pathlength 
multiplication factor for kidney tissue is not yet 
known, and thus the pathlength multiplication 
factor was taken to be 1 to allow comparison of 
data.
Changes in the absorbance at 775, 845 and 
904 nm can be converted to changes in the con­
centration of H b 02, Hb and redox changes in cyt 
aa3 by using matrix inversion incorporating analysis 
absorption coefficients of Hb, HbÔ2 and oxidized 
and reduced cyt aa3 at each of the above wave­
lengths used for this analysis. Further details of this 
analysis is given elsewhere [14, 22, 23]. The changes 
in concentration can be expressed as
AH b02 concentration =
( -1 .156 Ai4775) +(0.074 A A 845) +(1.428 A A904)
AHb concentration =
(1.641 A /l775) + ( —0.935 Ay4845) +  ( —0.178 A A go4)
ARedox changes of cyt aa3 —
( -  0.014 A/4775) +  (0.582 A A845) +  ( -  0.491 A^904)
where A refers to changes. The total haemoglobin 
(Hbtot) can be expressed as the sum of Hb and
H b 0 2.
The NIRS technique of monitoring cerebral total 
haemoglobin, cerebral blood volume and cerebral 
blood flow has been validated against other tech­
niques [14]. Validation of NIR multiplier coeffi­
cients shown above has also been done previously 
on in vitro preparations [24].
Protocol
Two NIRS instruments (BEMP, Keele University, 
U.K.) with laser firing synchronized by software 
(Desqview, Quarterdeck Office Systems, U.S.A.) 
were used to monitor both left and right kidneys 
simultaneously. Each kidney was transilluminated 
with near-infrared light via an optical fibre placed 
around it. The light emerging after absorption was 
collected by a similar optical fibre bundle, detected 
by an avalanche photodiode and amplified. The 
overall absorbance at each of three wavelengths, 
775, 845 and 904 nm, was detected and background 
light interference subtracted. Data from the instru­
ments were recorded every 4 s after initial calib­
ration against a glass filter of known absorbance 
(A). The calculated optical densities were stored and 
used in the algorithms.
Preparation
Male Sprague-Dawley rats (Charles Rivers, U.K.) 
of 400-500 g were anaesthetized using continuous 
left femoral arterial infusions of Saffan 
(Alphaxalone/Alphadolone, Pitman-Moore, U.K.) 
and maintained at 37°C. After tracheostomy, rats 
breathed room air. Both kidneys were exposed 
through an abdominal incision and kept moist with 
5% glucose/phosphate-bufffered saline. Small glass 
fibre-optic probes were placed on either side of each 
kidney by means of a specially designed probe 
holder. Physical pathlength was maintained at 1cm 
in all kidneys to enable comparison of data. Blood 
pressure was continuously monitored via a right 
femoral arterial cannula.
Rats (n=12) were randomly allocated to 80min 
left renal artery occlusion in the presence of either 
allopurinol (Wellcome Foundation, U.K.), or vehicle 
as controls. Eighty minutes of ischaemia has been 
shown previously to cause irreversible damage and 
was felt to be the time period where maximal 
benefit, if present, could be elicited. Changes in 
blood and tissue oxygenation were monitored for 
30min during which time allopurinol (50 mg/kg) 
was infused through the right femoral artery to be 
mixed with the aortic circulation. The left renal 
artery was occluded for 80min and an additional 
bolus of allopurinol (50 mg/kg) administered 5min 
before release, in order to ensure optimal response 
[25]. Control animals received pH-adjusted saline 
as both an infusion and a bolus. Both kidneys were 
monitored for a further 4.5 h of reperfusion and then 
excised for histological assessment of damage.
Results from experiments were calculated by tak­
ing two readings before occlusion, while during 
occlusion concentration changes were taken from 
the data every 5min. During reperfusion, changes 
were determined every 15min.
Histological assessment
Kidney sections were prepared for light micro­
scopy and assessed for ischaemic damage. A score 
using a scale of 0-5, where 5 corresponds to severe 
injury, was applied to changes in (1) glomeruli, (2) 
proximal tubules, (3) distal tubules and (4) conges­
tion in vessels. Using this semiquantitative method, 
morphological changes were statistically compared
[9].
?.
Statistical analysis
Data are reported as m eans+ SEM, unless other­
wise indicated, and n refers to the number of 
animals in each group. Differences were considered 
significant at the 5% level.
Data were analysed using repeated measures
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Fig. I. Changes in H b 0 2 concentration in response to 80min left renal ischaemia in allopurinol-treated and control rats 
(m e a n s ± S E M , /? =  6). — □ — f left control kidney; • • • O ’ “ . right control kidney; - - A * - *  left allopurinol-treated kidney.
analysis of variance, enabling the significance of 
differences between the control and allopurinol- 
treated group and differences between left and right 
kidneys with time to be tested together.
The scores obtained from the histological assess­
ment were tested for significant differences between 
left and right kidneys using a Wilcoxon test.
The histology between the allopurinol-treated and 
control groups was tested using the Kruskal-Wallis 
test of multiple comparisons (NCSS, J. L. Hintze, 
UT, U.S.A.).
RESULTS 
Ischaemia
Left renal ischaemia induced by renal artery 
occlusion resulted in a rapid decrease in both blood 
and tissue oxygenation.
The concentration change of HbOz fell from 
— 0.01+0.06 to — 0.36 + 0.03 mmol cm "11 ” 1 in the 
left control kidneys (Fig. 1). The concentration 
change in the left kidney of the allopurinol- 
treated group fell from 0.02 + 0.04 to —0.04 + 
0.05mmol cm "11“1. Ischaemia significantly reduced 
the H b 0 2 concentration change in the left kidney 
compared with the right in both the control and the 
allopurinol-treated groups (P<0.05). There were no 
significant differences in the H b 0 2 concentration 
change in response to ischaemia between the two 
groups.
Similarly, Hbtol demonstrated a significant 
decrease in the concentration change in response to 
ischaemia in both control and allopurinol-treated 
groups (P<0.05). The concentration change in 
controls dropped from —0.06 + 0.03 to —0.50+
0.06 mmol cm ~ 11"1, whereas in the allopurinol 
group the concentration change dropped from 
—0.01+0.04 to —0.53 + 0.02 mmol cm "11-1. Al­
though the degree of concentration change in Hbtot
in the two groups was not significantly different in 
response to ischaemia, the rate of concentration 
change during the ischaemic period was stable in 
the allopurinol group compared with the controls, 
which demonstrated a slow increase in Hbtot con­
centration change (P<0.05).
The concentration change in Hb fell slightly in 
response to ischaemia in both groups by up to 
„ 0.14mmol cm- 1 1-1. This change was not signifi­
cantly different from that in the right kidney as 
right kidney Hb concentration change also fell in 
the allopurinol group. Hb concentration change 
slowly increased (P<0.01) in the left kidney during 
ischaemia in the control group compared with the 
stable allopurinol group.
While there were obvious changes in the con­
centration of blood oxygenation due to ischaemia, a 
significant reduction in the concentration of oxi­
dized cyt aa3 was seen in the left kidneys of both 
groups compared with the right (P<0.05): from 
-0 .009 +  0.004 to —0.033+0.014 mmol cm- 1 1-1 in 
controls and from —0.006 + 0.002 to — 0.027 ±
0.011 mmol cm"11-1 in the allopurinol group (Fig. 
2). Since redox changes of cyt aa3, are monitored, 
an increase is interpreted as oxidation, while a 
decrease is interpreted as a reduction.
Reperfusion
Reperfusion of the left kidney of both groups with 
oxygenated blood occurred rapidly on release of the 
left renal artery. The most pronounced changes were 
seen during the first 30 min of reperfusion. Although 
the concentration change of H b 0 2 and Hb,ot in­
creased in control rats during this period, the rate of 
concentration change of H b 02 (P<0.05) and Hbtol 
was significantly enhanced by allopurinol (Fig. 1). 
The concentration changes of H b 0 2 and Hbtot 
reached preischaemic values after 4.5 h of reper-
362 D. L. Vaughan et al.
I
Eu
O
E
jE.
QJtXJc:atjdu
*uc:ou
oo
u
“O(UM
* « « * •-o><
O
0,01 -
0 -
0.01 -
0.02
0.03 '
0.04 -
0.05
0.06
" " l  1 ....1
Ischaemia
0
T
50
Reperfusion
T "
100
~ r
150
T
200
~ r
250
—r
300 350
Time (min)
Fig. 2. Changes in oxidized cyt aa3 concentration in response to 80 min left renal ischaemia in allopurinol-treated and 
control rats (means+SEM, n=6). Key as in Fig. I.
fusion in both groups. There were no significant 
differences in the concentration change of H b 02 
between left and right kidneys between 1 and 4.5 h 
of reperfusion.
The concentration change of Hb rose consider­
ably compared with the right kidney (PcO.Ol) 
during the first 15 min of reperfusion in the control 
group, increasing from —0.1+0.05 to 0.15 ±  
0.04 mmol cm "11 ~ 1 and falling back to stable values 
after 45 min, which'' were not significantly different 
from the right kidney. Hb concentrations in the 
allopurinol group rose only slightly during the first 
15 min of reperfusion to values not significantly 
different from those in the right kidney. The con­
centration changes of Hb during the last 3.5 h of 
reperfusion of the allopurinol group differed from 
those in the stable control group, in that the 
concentration change slowly increased in the left 
kidney compared with a slow decline in the right. 
Subsequently, the rate of change in the left kidney 
compared with the right of the allopurinol group 
was significantly different from that in the controls
(Pc0.05).
Cyt aa3, slowly oxidized in the left kidney during 
the first 30min of reperfusion (.PcO.Ol) in both 
groups (Fig. 2). Allopurinol significantly increased 
the rate of oxidation of cyt aa3 in the left kidney 
during early reperfusion (P <  0.05). During the entire
4.5 h of reperfusion the concentration change of 
oxidized cyt aa3 increased in the allopurinol group 
compared with the stable control group, which 
demonstrated large variations in concentration 
change. Because of these large variations, however, 
this was not found to be significant.
Histology
Ischaemic damage was confirmed both in the left 
kidneys (16 + 4) of the control group compared with
the right (7 ±4) and in the left kidneys (15 +  3) of 
the allopurinol group compared with the right 
(7 +  3) (PcO.Ol) (mean scores +  SD). Histologically, 
allopurinol showed little effect upon the morpholo­
gical changes associated with ischaemic damage as 
assessed by the scoring method.
DISCUSSION
This study demonstrates that allopurinol admin­
istered before both ischaemia and reperfusion 
improves the rate of renal perfusion with oxygen­
ated blood and improves tissue oxygenation as 
assessed by the redox state of cyt aa3 in the 
reperfusion phase. As anticipated, no histological 
benefit was seen with allopurinol within this very 
early phase of reperfusion.
In ischaemic kidneys, red blood cells become 
trapped within the microvasculature of the outer 
medulla [26-32]. Reperfusion is clearly dependent 
upon the number of red blood cells trapped and 
their speed of clearance. The pretreatment of rats 
with allopurinol before ischaemia has been shown 
to elevate renal blood flow, lower renal vascular 
resistance and prevent erythrocyte accumulation in 
the medulla [33]. This finding would be supported 
by the demonstrated increase in the rate of reper­
fusion seen in this work.
The effect of allopurinol in tissue oxygenation is 
clear compared with controls. The rate of oxidation 
of cyt aa3 is significantly increased during early 
reperfusion. In the control group there was also 
considerably more variation in the redox state of cyt 
aa3 during the later stages of reperfusion. The 
increase in tissue oxygenation in the presence of 
allopurinol may be a result of increased reperfusion 
with oxygenated blood to areas which may other­
wise remain hypoxic in the control group. NIRS in
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this situation monitors whole-organ blood oxygena­
tion so that the contribution of small areas of 
hypoxia may or may not be important compared 
with global kidney oxygenation.
The findings in tissue oxygenation seen in this 
study differ from our earlier studies designed to 
compare the severity of injury associated with 45 
and 80 min of ischaemia followed by reperfusion [9] 
in two ways. Firstly, improvements to the monitor­
ing system had been made after the said earlier 
study and most importantly, the controls in this 
study were not the same controls as described in the 
earlier study [9]. Secondly, the rats in the 45/80 min 
ischaemic groups did not receive an infusion of pH- 
adjusted saline for 30 min before ischaemia or a 
bolus before reperfusion, therefore the discrepancy 
between the two sets of data may reflect the effect of
haemodilution.
Allopurinol is also known to have further com­
plementary cellular effects in addition to its haemo- 
dynamic effects. Firstly it is an inhibitor of xanthine 
oxidase, thus enabling ATP to be regenerated from 
hypoxanthine and inhibiting the formation of reac­
tive oxygen species, a product of xanthine oxidase 
activity [11]. Secondly, allopurinol has been shown 
to be a scavenger of hydroxyl radicals [12]. Finally, 
allopurinol has been shown to facilitate the transfer 
of electrons from the ferrous ion to ferric cyto­
chrome c, which enhances the electron transport 
system during reperfusion [13]. If allopurinol is 
administered just before reperfusion, inhibition of 
xanthine oxidase enables hypoxanthine to be used 
to generate ATP, instead of being lost from the cell 
as uric acid [11]. Cell viability is related to its 
energy metabolism and importantly the ability to 
resynthesize ATP during reperfusion [34]. The 
improved rate of oxidation of cyt aa3 in this study 
may reflect an improved cellular and mitochondrial 
viability in the allopurinol group, as allopurinol has 
also been shown to protect the structure and func­
tional integrity of mitochondria [35]. As allopurinol 
can facilitate the transfer of electrons from the 
ferrous iron to ferric cytochrome c in the respiratory 
chain, electron transport may be enhanced during 
reperfusion irrespective of mitochondrial lipid mem­
brane damage [12]. Allopurinol may therefore inde­
pendently enhance the respiratory chain, increasing 
the rate of cyt aa3 oxidation.
While the beneficial effects of allopurinol upon 
ischaemia-reperfusion injury were demonstrated 
using NIRS, no histological benefit was seen. This 
may suggest that monitoring subtle changes in 
blood and tissue oxygenation is a more sensitive 
method of revealing early beneficial properties of 
interventional therapies. The greatest morphological 
changes which occur as a result of these subtle 
changes in tissue oxygenation may be most evident 
not 4h  after reperfusion, as in this study, but days 
after the initial ischaemic injury. In addition, al­
though the semiquantitative method of assessing the 
morphological damage in kidneys may allow statis­
tical comparison of the changes occurring, it is not 
fully quantitative, no measurements are actually 
performed and, with a limited scoring system, its 
sensitivity is comparatively low.
Thus, this study supports previous observations 
of the beneficial effects of allopurinol in this type of 
renal injury and demonstrates its effects in blood 
and tissue oxygenation. Whether allopurinol should 
be advocated in the treatment regimen for patients 
at risk from ischaemia-reperfusion injury is a 
question for further consideration. While the dose of 
allopurinol used in this study could be considered 
high in the context of treating patients with gout 
(maximum oral maintenance dose 900 mg/day; 
British National Formulary), it was administered 
directly into the circulation as a single preventative 
dose regimen to reduce the damage associated with 
ischaemia-reperfusion injury. This dose is most 
commonly quoted in experimental studies of 
ischaemia-reperfusion injury, i.e. 50 mg/kg as both 
an infusion and bolus in liver [22], 40 mg/kg in 
studies of renal failure [36] and 100 mg/kg as a 4-h 
infusion in aminonucleoside nephrosis [37]. Any 
adverse reactions accompanying a single dose ad­
ministered over a short period may be different 
from those associated with a lower maintenance 
dose. Severe adverse reactions to a drug may be 
tolerated more readily than life-threatening acute 
renal failure resulting from the injuries associated 
with ischaemia-reperfusion injury. The purpose of
this study was not, however, to propose immediately 
a treatment regimen for patients at risk from 
ischaemia-reperfusion injury, but to determine 
whether NIRS could be used to reveal the beneficial 
effects of a drug in reducing injuries associated with 
ischaemia-reperfusion. As this has never been 
demonstrated before, a drug regimen was selected to 
ensure the maximum protection against ischaemia- 
reperfusion injury to ensure maximum response in 
terms of the experimental set-up.
In conclusion, NIRS is a valuable approach to 
the investigation of haemodynamic and cellular 
effects of interventional strategies designed to mini­
mize ischaemia-reperfusion injury.
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